D1 receptor regulation of preprotachykinin-A gene by extracellular signal-regulated kinase pathway in striatal cultures

NeuroReport

Volumn 19, Issue 2, 2008, Pages 187-191

  Sin, Mihaela ^a   Michelhaugh, Sharon K ^a   Bannon, Michael J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; Dopamine D1 receptor; Extracellular signal regulated kinase 1 2; Mitogen associated protein kinase; Organotypic culture; Parkinson's disease; Preprotachykinin A; Striatum; Substance P

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PREPROTACHYKININ; PREPROTACHYKININ A; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; GENE EXPRESSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MODELS, ANIMAL; NEURONS; ORGAN CULTURE TECHNIQUES; PARKINSON DISEASE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; TACHYKININS;

EID: 38049134892     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3282f35595     Document Type: Article

References (25)

1. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007; 64:20-24.
2. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990; 250:1429-1432.
3. Gerfen CR, Miyachi S, Paletzki R, Brown P. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J Neurosci 2002; 22: 5042-5054.
4. Kim DS, Palmiter RD, Cummins A, Gerfen CR. Reversal of super-sensitive striatal dopamine D1 receptor signaling and extracellular signal-regulated kinase activity in dopamine-deficient mice. Neuroscience 2006; 137:1381-1388.
5. Berke JD, Paletzki RF, Aronson GJ, Hyman SE, Gerfen CR. A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci 1998; 18:5301-5310.
6. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci 2004; 74:1445-1463.
7. Haverstick DM, Rubenstein A, Bannon MJ. Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors. J Pharmacol Exp Ther 1989; 248:858-862.
8. Haverstick DM, Bannon MJ. Evidence for dual mechanisms involved in methamphetamine-induced increases in striatal preprotachykinin mRNA. J Biol Chem 1989; 264:13140-13144.
9. Fernandez A, de Ceballos ML, Jenner P, Marsden CD. Striatal neuropeptide levels in Parkinson's disease patients. Neurosci Lett 1992; 145:171-174.
10. Nisenbaum LK, Kitai ST, Crowley WR, Gerfen CR. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion. Neuroscience 1994; 60:927-937.
11. Bannon MJ, Lee JM, Giraud P, Young A, Affolter HU, Bonner TI. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. J Biol Chem 1986; 261:6640-6642.
12. Sivam SP. Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem parkinsonian brains. Neuropeptides 1991; 18:201-207.
13. Calin-Jageman IE, Wang J, Bannon MJ. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism. J Neurochem 2006; 97:255-264.
14. Kovacs KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux JR. C/EBPbeta couples dopamine signalling to substance P precursor gene expression in striatal neurones. J Neurochem 2006; 98:1390-1399.
15. Kessler JA, Freidin MM, Kalberg C, Chandross KJ. Cytokines regulate substance P expression in sympathetic neurons. Regul Pept 1993; 46:70-75.
16. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1986.
17. Campbell BM, Walker PD. Striatal preprotachykinin mRNA levels are regulated by stimulatory agents and dopamine D1 receptor manipulation in rodent organotypic slice cultures. Brain Res 2001; 888:26-33.
18. Gresch PJ, Walker PD. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease. Neuroscience 1999; 93:831-841.
19. Roberson ED, English JD, Adams JP, Selcher JC, Kondratick C, Sweatt JD. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci 1999; 19:4337-4348.
20. Wang J, Michelhaugh SK, Bannon MJ. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells. Eur J Neurosci 2007; 25:1982-1986.
21. Neve KA, Seamans JK, Trantham-Davidson H. Dopamine receptor signaling. J Recept Signal Transduct Res 2004; 24:165-205.
22. Zanassi P, Paolillo M, Feliciello A, Avvedimento EV, Gallo V, Schinelli S. cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ ERK-dependent pathway in striatal neurons. J Biol Chem 2001; 276: 11487-11495.
23. Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JC, et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A 2005; 102:491-496.
24. Zhang L, Lou D, Jiao H, Zhang D, Wang X, Xia Y, et al. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 2004; 24:3344-3354.
25. Hetman M, Gozdz A. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 2004; 271:2050-2055.